Editor in Chief Dr KK Aggarwal, Padma Shri Awardee                                                                               Dated:13 July,2020

No proof MMR vaccination offers protection against Covid-19, says Serum Institute

PUNE: Pune-based vaccine major Serum Institute of India (SII) said there is no direct evidence to prove that the measles-mumps-rubella (MMR) vaccine offers protection against Covid-19. ,The SII is one of the key manufacturers of the MMR vaccine in the country.
The institute’s statement to TOI on Sunday comes amidst nationwide reports of adults queuing up for MMR vaccination in hopes of a defence against the coronavirus. The MMR is administered to infants at nine months of age. ,Before the interest in MMR, there were theories on the supposed protection offered by the anti-TB BCG vaccine. ....read more


CMAAO Coronavirus Facts and Myth Buster: Airborne transmission and WHO; Tocilizumab treatment

New WHO Guidance Calls for More Evidence on Airborne Transmission
The WHO released new guidance on Thursday on the transmission of the novel coronavirus acknowledging certain reports of airborne transmission; however, the agency stopped short of confirming that the virus spreads through the air. ,The agency further acknowledged that some outbreak reports pertaining to indoor crowded spaces point to the likelihood of aerosol transmission, such as during choir practice, in restaurants or in fitness classes. ,WHO stated that the coronavirus causing COVID-19 spreads through contact with contaminated surfaces or close contact with infected individuals who tend to spread the virus through saliva, respiratory secretions or droplets that are released when an infected person coughs, sneezes, speaks or sings. ....read more


CMAAO Coronavirus Facts and Myth Buster - Best time to donate plasma is 28 to 40 days

COVID-19 Plasma Donors have Higher Levels of IgG 28 Days after Symptom Onset
IgG in COVID-19 convalescent plasma donors seems to attain higher levels four weeks after symptom onset, thus pointing that this is the optimal time to collect plasma. A study of 49 convalescent plasma donors revealed that plasma levels were lower when the donation occurred less than 28 days from the symptom onset in comparison to levels in patients who donated after four weeks. The results were published in Transfusion....read more


Sattchittaananda: The soul characteristics (Absolute Existence - Absolute Knowledge)

Satt means ‘truth or knowingness’
Chitta means ‘consciousness-based’
The soul in Vedic description is described as Sattchittaananda. People in touch with their soul speak the truth, take consciousness-based decisions and experience inner happiness. ,The great rishis of India have described a formula of how to be in touch with your soul and get inner happiness. The formula is based on three questions, which you should ask yourself before performing any action. ....read more


Video of The day

In COVID 19 try this antibiotic also


Medbytes

       


Healthcare News Monitor
World's first Covid-19 vaccine? Russia successfully completes clinical trials
Live mint

After over six months of novel coronavirus outbreak, which has infected more than 12 million people and killed over 500,000 all over the world, the clinical trials of the purportedly world's first coronavirus vaccine have been successfully completed. ,The clinical trials of the world's first coronavirus vaccine on volunteers at Sechenov First Moscow State Medical University has been successfully completed, Vadim Tarasov, the director of the Institute for Translational Medicine and Biotechnology, according to Russian news agency Sputnik, adding that the first group of volunteers would be discharged on 15 July and the second on 20 July.

India to reduce over-dependence on Chinese pharmaceutical raw materials
HT

India is considering importing certain active pharmaceutical ingredients (APIs) and intermediaries from alternative sources such as the United States, Italy, Singapore and Hong Kong, leading to ramping up domestic capacity in a bid to reduce dependence on China, two officials aware of development said.
Over 63 per cent of India’s pharmaceutical imports are API and intermediates, and almost 70 per cent of it comes from China. Dependence on a single country for such crucial thing is not prudent in India’s national interest, hence there is a need to diversify its sourcing and develop domestic capacity, the officials said requesting anonymity.

Delhi: Doctor, associate arrested for issuing fake medical certificates to help criminals get bail
India Today

The team of STARS-2, Crime Branch has arrested one doctor Gajender Kumar Nayyar and his associate Mukesh Sangwan for their involvement in issuing fake medical certificates to accused, convicts. They were also involved in issuing the fake medical documents to family members of accused and convicts for extraneous consideration to facilitate them in obtaining favorable orders of bail, interim bail and suspension of sentence. Accused Mukesh Sangwan used to provide clients to the doctor.
On June 29, High Court of Delhi passed an order on bail application in case of Abdul Rehman Nawali Vs State to conduct an inquiry into the allegations raised by the prosecution that Dr Gajender Kumar Nayyar is issuing fake medical certificates. During the enquiry, it was found that Dr Gajender Kumar Nayyar is registered with Delhi Medical Council and is under suspension till November 29, 2020 for professional misconduct since March 29, 2019. During the suspension time he has been issuing medical certificates. A case under appropriate sections was registered at PS Crime Branch, Delhi and investigation was taken up.

COVID-19 vaccine: India to begin human clinical trials; Patna AIIMS selects 18 volunteeers
DNA

After Russia became the first country to successfully conclude human trials for the world's premier coronavirus vaccine, India is set to begin the human clinical trials for vaccines against the SARS-CoV-2, the virus that causes the dreaded coronavirus disease (COVID-19). For the purpose of the trials, the All India Institute of Medical Sciences (AIIMS) in Patna has selected 18 volunteers on whom the vaccine trails will be conducted. ,According to sources, the hospital authority is set to begin the human trials of the vaccine from today (i.e. July 13, Monday). ,Till now, only the Bharat Biotech International Ltd and the Zydus Cadila pharmaceutical companies' indigenously developed vaccine prototypes have got an approval for the human trials from the Drugs Controller General of India.